1. Home
  2. RGR vs ARCT Comparison

RGR vs ARCT Comparison

Compare RGR & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGR
  • ARCT
  • Stock Information
  • Founded
  • RGR 1949
  • ARCT 2013
  • Country
  • RGR United States
  • ARCT United States
  • Employees
  • RGR N/A
  • ARCT N/A
  • Industry
  • RGR Ordnance And Accessories
  • ARCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • RGR Industrials
  • ARCT Health Care
  • Exchange
  • RGR Nasdaq
  • ARCT Nasdaq
  • Market Cap
  • RGR 610.8M
  • ARCT 487.0M
  • IPO Year
  • RGR N/A
  • ARCT N/A
  • Fundamental
  • Price
  • RGR $35.60
  • ARCT $15.88
  • Analyst Decision
  • RGR
  • ARCT Strong Buy
  • Analyst Count
  • RGR 0
  • ARCT 8
  • Target Price
  • RGR N/A
  • ARCT $61.00
  • AVG Volume (30 Days)
  • RGR 126.1K
  • ARCT 405.9K
  • Earning Date
  • RGR 02-19-2025
  • ARCT 03-06-2025
  • Dividend Yield
  • RGR 1.94%
  • ARCT N/A
  • EPS Growth
  • RGR N/A
  • ARCT N/A
  • EPS
  • RGR 1.73
  • ARCT N/A
  • Revenue
  • RGR $520,485,000.00
  • ARCT $160,399,000.00
  • Revenue This Year
  • RGR N/A
  • ARCT $7.33
  • Revenue Next Year
  • RGR $4.81
  • ARCT $4.71
  • P/E Ratio
  • RGR $20.50
  • ARCT N/A
  • Revenue Growth
  • RGR N/A
  • ARCT N/A
  • 52 Week Low
  • RGR $34.11
  • ARCT $14.30
  • 52 Week High
  • RGR $48.20
  • ARCT $45.00
  • Technical
  • Relative Strength Index (RSI)
  • RGR 47.22
  • ARCT 41.74
  • Support Level
  • RGR $34.98
  • ARCT $16.03
  • Resistance Level
  • RGR $36.57
  • ARCT $17.95
  • Average True Range (ATR)
  • RGR 0.70
  • ARCT 1.29
  • MACD
  • RGR 0.03
  • ARCT -0.07
  • Stochastic Oscillator
  • RGR 30.24
  • ARCT 10.29

About RGR Sturm Ruger & Company Inc.

Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The Company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.

Share on Social Networks: